Russell Investments Group, Ltd. Theravance Biopharma, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 47,098 shares of TBPH stock, worth $457,792. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,098

Previous 50,518 6.77%

Holding current value

$457,792

Previous $428,000 11.45%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$7.66 - $10.25 $26,197 - $35,055	-3,420 Reduced 6.77%	47,098 $379,000
Q2 2024 Aug 08, 2024	BUY	$8.29 - $9.92 $44,799 - $53,607	5,404 Added 11.98%	50,518 $428,000
Q1 2024 May 08, 2024	BUY	$8.22 - $11.59 $132,629 - $187,004	16,135 Added 55.68%	45,114 $404,000
Q4 2023 Feb 05, 2024	SELL	$8.58 - $11.4 $150,355 - $199,773	-17,524 Reduced 37.68%	28,979 $325,000
Q3 2023 Nov 13, 2023	SELL	$8.38 - $10.44 $59,623 - $74,280	-7,115 Reduced 13.27%	46,503 $401,000
Q2 2023 Aug 10, 2023	SELL	$10.16 - $11.92 $195,437 - $229,293	-19,236 Reduced 26.4%	53,618 $554,000
Q1 2023 May 09, 2023	BUY	$9.87 - $11.44 $819 - $949	83 Added 0.11%	72,854 $790,000
Q4 2022 Feb 08, 2023	BUY	$9.65 - $11.34 $133,179 - $156,503	13,801 Added 23.4%	72,771 $816,000
Q3 2022 Nov 04, 2022	SELL	$8.39 - $10.22 $60,332 - $73,492	-7,191 Reduced 10.87%	58,970 $596,000
Q2 2022 Jul 29, 2022	SELL	$8.41 - $10.34 $42,756 - $52,568	-5,084 Reduced 7.14%	66,161 $598,000
Q1 2022 May 05, 2022	SELL	$8.33 - $12.96 $341,155 - $530,776	-40,955 Reduced 36.5%	71,245 $680,000
Q4 2021 Jan 21, 2022	BUY	$7.42 - $11.05 $328,112 - $488,631	44,220 Added 65.05%	112,200 $1.24 Million
Q3 2021 Nov 08, 2021	SELL	$6.77 - $14.41 $94,874 - $201,941	-14,014 Reduced 17.09%	67,980 $501,000
Q2 2021 Aug 04, 2021	SELL	$14.52 - $22.46 $74,458 - $115,174	-5,128 Reduced 5.89%	81,994 $1.19 Million
Q1 2021 May 10, 2021	SELL	$16.57 - $21.08 $266,876 - $339,514	-16,106 Reduced 15.6%	87,122 $1.78 Million
Q4 2020 Feb 08, 2021	SELL	$14.89 - $20.16 $147,961 - $200,329	-9,937 Reduced 8.78%	103,228 $1.83 Million
Q3 2020 Nov 09, 2020	BUY	$14.79 - $22.49 $251,326 - $382,172	16,993 Added 17.67%	113,165 $1.67 Million
Q2 2020 Aug 05, 2020	BUY	$20.64 - $30.69 $284,914 - $423,644	13,804 Added 16.76%	96,172 $2.02 Million
Q1 2020 May 06, 2020	BUY	$17.84 - $31.21 $1.3 Million - $2.28 Million	72,968 Added 776.26%	82,368 $1.9 Million
Q4 2019 Jan 29, 2020	BUY	$16.12 - $25.89 $151,528 - $243,366	9,400 New	9,400 $243,000
Q4 2017 Feb 06, 2018	SELL	$25.82 - $35.66 $477,876 - $659,995	-18,508 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$23.88 - $34.96 $441,971 - $647,039	18,508	18,508 $634,000

Others Institutions Holding TBPH

# of Institutions

126

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $649M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Theravance Biopharma, Inc. Transaction History